简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-04-15 10:09 Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
2026-04-10 14:29 ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
2026-04-09 16:04 Americhem Announces Expansion of Global Healthcare Footprint with New China Investment at Chinaplas 2026
2026-04-09 13:35 Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
2026-04-08 10:12 Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis
2026-04-03 14:17 IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs
2026-04-02 13:44 Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
2026-04-02 13:39 VDYNE Receives FDA Approval to Initiate the TRIVITA1 IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System
2026-04-02 11:19 Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond
2026-04-01 10:34 WHOOP Raises $575 Million at $10.1 Billion Valuation to Advance Global Health Platform
2026-04-01 09:38 Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
2026-03-31 10:48 HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)
2026-03-31 10:24 Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform
2026-03-30 14:13 Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
2026-03-30 11:24 AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
2026-03-27 10:54 Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification
2026-03-25 13:28 Perceptive eClinical and Kayentis Partner to Deliver Integrated eCOA–IRT Solution That Reduces Digital System Complexity in Global Clinical Trials
2026-03-24 14:15 Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
2026-03-24 14:05 AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
2026-03-23 16:04 Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

Business Wire Weibo

Press Releases

Latest Releases